This cross-sectional study aimed to compare growth, nutritional status and body composition outcomes between a group of 94 HIV-infected children and adolescents on antiretroviral therapy (ART) and 364 healthy controls, and to evaluate their association with clinical and lifestyle variables within the HIV-infected group. When compared with the control group, HIV patients had higher risk of stunting (odds ratio [OR] 5.33, 95% confidence interval [CI]: 2.83–10.04) and thinness (OR 4.7, 95% CI: 2.44–9.06), higher waist-to-hip ratios (medians 0.89 versus 0.82 for boys and 0.90 versus 0.77 for girls, P < 0.001), and lower prevalence of overweight or obesity (OR 0.33, 95% CI: 0.14–0.78). Protease inhibitor usage was associated with thinness (OR 3.51, 95% CI 1.07–11.44) and lipoatrophy (OR 3.5, 95% CI 1.37–8.95). HIV-infected children on ART showed significant nutritional status and body composition abnormalities, consistent with the severity of vertical HIV infection and the consequences of prolonged ART.
Brazil. Ministry of Health, Secretary of Health Surveillance, National Program on Sexually Transmitted Diseases and AIDS. Recommendations for Antiretroviral Therapy in HIV – Infected Children and Adolescents: Pocket Handbook. Brasília: Ministry of Health, 2009. Portuguese
2.
Leandro-MerhiVA, VilelaMMS, da SilvaMTN, Evolution of nutritional status of infants infected with the human immunodeficiency virus. Sao Paulo Med J2000;118:148–53
3.
The European Collaborative Study. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. The European Collaborative Study. Pediatrics2003;111:52–60
4.
BradyMT, OleskeJM, WilliamsPL, Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr2010;53:86–94
5.
PalladinoC, BellónJM, JarrínI, Impact of highly active antiretroviral therapy (HAART) on AIDS and death in a cohort of vertically HIV type 1-infected children: 1980–2006. AIDS Res Hum Retroviruses2009;25:1091–7
6.
HackerMA, KaidaA, HoggRS, BastosFI. The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996–2006. Cad Saúde Públic2007;23:345–59
7.
AnuuradE, SemradA, BerglundL. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease. Metab Syndr Relat Disord2009;7:401–10
8.
McComseyGA, LeonardE. Metabolic complications of HIV therapy in children. AIDS2004;18:1753–68
9.
FlorindoAA, de Oliveira Latorre MdoR, JaimePC, SeguradoAA. Leisure time physical activity prevents accumulation of central fat in HIV/AIDS subjects on highly active antiretroviral therapy. Int J STD AIDS2007;18:692–6
10.
SamarasK, WandH, LawM, Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism. Curr HIV Res2009;7:454–61
11.
SouzaDT, RondóPH, ReisLC. The nutritional status of children and adolescents with HIV/AIDS on antiretroviral therapy. J Trop Pediatr2010;0:1–4
12.
Center for Disease Control. Revised Classification System for Human Immunodeficiency Virus Infection in Children Less Than 13 Years of Age MMWR. CDC 1994;43:1–10
National Center for Health Statistics. 2000 CDC Growth Charts for the United States: Methods and Development. Series Report 11, 246. Washington, 2000. p. 201.
15.
ColeTJ, FlegalKM, NichollsD, Body mass index cut offs to define thinness in children and adolescents: international survey. BMJ2007;335:194–9
16.
ColeTJ, BellizziMC, FlegalKM, Establishing a standard definition for child Survey overweight and obesity worldwide: international. BMJ2000;320:1240–3
17.
SlaughterMH, LohmanTG, BoileauRA, Skinfold equations for estimation of body fatness in children and youth. Hum Biol1988;60:709–23
18.
MarshallWA, TannerJM. Variations in pattern of pubertal changes in girls. Arch Dis Child1969;44:291–303
19.
CarrA, EmeryS, LawM, HIV Lipodystrophy Case Definition Study Group. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet2003;361:726–35
20.
MatsudoS, AraujoT, MatsudoV, Questionário Internacional de Atividade Física (IPAQ): estudo de reprodutibilidade no Brasil. Revista Brasileira de Atividade Física e Saúde2001;6:5–18
21.
CrockerPR, BaileyDA, FaulknerRA, Measuring general levels of physical activity: preliminary evidence for the physical activity questionnaire for older children. Med Sci Sports Exerc1997;29:1344–9
22.
Subcommittee on the Tenth Edition of the RDAs. Food and Nutrition Board. Commission of Life Sciences. National Research Council. Recommended Dietary Allowances. 10th edn.Washington, DC: National Academy Press, 1989
23.
CentevilleM, MorcilloAM, Barros Filho AdeA, Lack of association between nutritional status and change in clinical category among HIV-infected children in Brazil. Sao Paulo Med J2005;23:62–6
24.
European Paediatric Lipodystrophy Group. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe. AIDS2004;18:1443–51
25.
GuillénS, RamosJT, ResinoR, Impact on weight and height with the use of HAART in HIV-infected children. Pediatr Infect Dis J2007;26:334–8
26.
AurpibulL, PuthanakitT, TaecharoenkulS, Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor–based antiretroviral therapy. AIDS Patient Care STDs2009;23:1067–71
27.
ShetA, MehtaS, RajagopalanN, Anemia and growth failure among HIV-infected children in India: a retrospective analysis. BMC Pediatr2009;16:37–45
28.
BobatR, CoovadiaH, MoodleyD, Growth in early childhood in a cohort of children born to HIV-1 infected women from Durban, South Africa. Ann Trop Paediatr2001;21:203–10
29.
ChantryCJ, FrederickMM, MeyerWA, Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children. Pediatr Infect Dis J2007;26:53–60
30.
ArpadiSM, BethelbJ, HorlickaM, Longitudinal changes in regional fat content in HIV-infected children and adolescents. AIDS2009;23:1501–9
31.
BuonoraS, NogueiraS, PoneMV, Growth parameters in HIV-vertically-infected adolescents on antiretroviral therapy in Rio de Janeiro, Brazil. Ann Trop Paediatr2008;28:59–64
32.
KruzichLA, MarquisGS, WilsonCM, StephensenCB. HIV-infected US youth are at high risk of obesity and poor diet quality: a challenge for improving short- and long-term health outcomes. J Am Diet Assoc2004;104:1554–60
33.
Crum-CianfloneN, TejidorR, MedinaS, BarahonaI, GanesanA. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS2008;22:925–30
34.
AurpibulL, PuthanakitT, LeeB, Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Antivir Ther2007;12:1247–54
35.
DasS. Risk of cardiovascular disease in HIV-infected patients. J Antimicrob Chemother2010;65:386–9
36.
SacherPM, KolotourouM, ChadwickPM, Randomized controlled trial of the MEND program: a family-based community intervention for childhood obesity. Obesity2010;18:62–8
